Page last updated: 2024-08-22

n-methylaspartate and sib 1893

n-methylaspartate has been researched along with sib 1893 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bräuner-Osborne, H; Egebjerg, J; Krogsgaard-Larsen, P; Madsen, U; Nielsen, EO1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Battaglia, G; Bruno, V; Flor, PJ; Gasparini, F; Ksiazek, I; Kuhn, R; Leonhardt, T; Lukic, S; Nicoletti, F; Sauer, D1
Faden, AI; Movsesyan, V; O'Leary, DM; Vicini, S1
Bao, W; Faden, AI; Fan, L; Knoblach, SM; Movsesyan, VA; Mullins, PG; O'Leary, DM1

Reviews

1 review(s) available for n-methylaspartate and sib 1893

ArticleYear
Ligands for glutamate receptors: design and therapeutic prospects.
    Journal of medicinal chemistry, 2000, Jul-13, Volume: 43, Issue:14

    Topics: Animals; Drug Design; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Humans; Ligands; N-Methylaspartate; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Synapses

2000

Other Studies

4 other study(ies) available for n-methylaspartate and sib 1893

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective.
    Neuropharmacology, 2000, Volume: 39, Issue:12

    Topics: Amyloid beta-Peptides; Animals; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Antagonists; Male; Mice; N-Methylaspartate; Nerve Degeneration; Neuroglia; Neurons; Neuroprotective Agents; Phenazopyridine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate

2000
Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
    British journal of pharmacology, 2000, Volume: 131, Issue:7

    Topics: Animals; Cell Death; Cells, Cultured; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Fetus; Glutamic Acid; Glycine; Hydrolysis; Membrane Potentials; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Phenylacetates; Phosphatidylinositols; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate

2000
mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:1

    Topics: Animals; Brain Injuries; Cell Survival; Cells, Cultured; Cerebral Cortex; Electrophysiology; Excitatory Amino Acid Antagonists; Glutamic Acid; Hydrolysis; Male; Maze Learning; Memory; N-Methylaspartate; Neurons; Neuroprotective Agents; Phosphatidylinositols; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate

2001